New health insurance plan launched by LIC
LIC is launching its new non-linked health insurance plan ‘Jeevan Arogya’ from tomorrow offering comprehensive hospitalisation benefits for the family of the principal insured.
LIC is launching its new non-linked health insurance plan ‘Jeevan Arogya’ from tomorrow offering comprehensive hospitalisation benefits for the family of the principal insured.
The fully automated DR Suite helps capture high-quality digital radiographs, while achieving faster patient exam time.
Healthcare experts widely agree that computerised records can help doctors and hospitals avoid medical errors and improve the quality of care.
The testing of electronic medical records (EMR) was a trending topic at the 11th annual IHE European Connectathon that took place April 11-15 in Pisa, Italy.
When people get ill, one first thinks of possible reasons and then tries to get some medicine from a drug store or a clinic, which can only offer medicine according to oral description about symptoms.
Round-the-clock health services will be provided by Haryana’s health department at all primary health centres and community health centres in the state.
The new Board of Governors for the Medical Council of India (MCI) has appointed Cardiologist Dr. K.K. Talwar as the Chairman.
Millions of Americans turn to the Internet for medical information, according to a new study by the Pew Research Center
Rajiv Aarogyasri, a government initiated health insurance scheme (working on a public-private partnership model) running in Andhra Pradesh is providing cashless treatment to almost 90 percent of the state population
Dr Ajay Singla, Additional Secretary, Health & Family Welfare, Government of NCT of Delhi and CEO, Aapka Swasthya Bima Yojana is one of the most dynamic healthcare leaders and visionaries in the country.
To help finance high-end medical devices for patients, the Medical technology company Medtronic has come up with affordable projects.
Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level.